Semaglutide is revolutionizing kidney disease treatment for type 2 diabetes patients. Learn how it works and its potential ...

GPs struggle to integrate albuminuria screening for chronic kidney disease due to confusion over prescribing and interpreting ...

Diabetes is the leading cause of kidney failure, and there are estimated to be almost 850 million people worldwide with chronic kidney disease (CKD), including 160 million with type 2 diabetes.

No randomized clinical trials have directly compared empagliflozin with dapagliflozin for type 2 diabetes, so investigators conducted a large comparative effectiveness study examining kidney outcomes.

In summary, the study introduced a more precise way to measure kidney function in older adults by accounting for age-related ...

New Model for Replication of BKPyV Virus, a Major Cause of Kidney Transplant Failure Dec. 6, 2024 — BK polyomavirus, or BKPyV, is a major cause of kidney transplant failure. There are no ...

The results of this cohort study suggest that individuals with type 2 diabetes who initiated treatment with empagliflozin or ...

We speak to him about the company’s drive to tackle the complications of type 2 diabetes, such as chronic kidney disease, and how they see the future unfolding with GLP-1 agonists and beyond.

Continuous glucose monitors have been found to predict complications in patients with Type 1 diabetes. Read more!

Annual health checkups regularly include urine tests that serve several purposes, including checking for symptoms of kidney ...

People often let chronic conditions such as high blood pressure and diabetes go for a long time without treatment. Here’s why ...